NDC 51662-1566
DOBUTAMINE HYDROCHLORIDE
Dobutamine Hydrochloride
DOBUTAMINE HYDROCHLORIDE is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co Llc, Dba Healthfirst. The primary component is Dobutamine Hydrochloride.
| Product ID | 51662-1566_c6cfbe58-1ec0-28dd-e053-2a95a90a193a |
| NDC | 51662-1566 |
| Product Type | Human Prescription Drug |
| Proprietary Name | DOBUTAMINE HYDROCHLORIDE |
| Generic Name | Dobutamine Hydrochloride |
| Dosage Form | Injection |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2021-07-10 |
| Marketing Category | NDA / |
| Application Number | NDA020255 |
| Labeler Name | HF Acquisition Co LLC, DBA HealthFirst |
| Substance Name | DOBUTAMINE HYDROCHLORIDE |
| Active Ingredient Strength | 100 mg/100mL |
| Pharm Classes | Adrenergic beta-Agonists [MoA],beta-Adrenergic Agonist [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |